FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:TMEM165-DACH1

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: TMEM165-DACH1
FusionPDB ID: 91755
FusionGDB2.0 ID: 91755
HgeneTgene
Gene symbol

TMEM165

DACH1

Gene ID

55858

1602

Gene nametransmembrane protein 165dachshund family transcription factor 1
SynonymsCDG2K|FT27|GDT1|TMPT27|TPARLDACH
Cytomap

4q12

13q21.33

Type of geneprotein-codingprotein-coding
Descriptiontransmembrane protein 165TPA regulated locustransmembrane protein PT27transmembrane protein TPARLdachshund homolog 1dac homolog
Modification date2020031320200328
UniProtAcc.

Q9UI36

Main function of 5'-partner protein: FUNCTION: Transcription factor that is involved in regulation of organogenesis. Seems to be a regulator of SIX1, SIX6 and probably SIX5. Corepression of precursor cell proliferation in myoblasts by SIX1 is switched to coactivation through recruitment of EYA3 to the SIX1-DACH1 complex. Transcriptional activation seems also to involve association of CREBBP. Seems to act as a corepressor of SIX6 in regulating proliferation by directly repressing cyclin-dependent kinase inhibitors, including the p27Kip1 promoter (By similarity). Inhibits TGF-beta signaling through interaction with SMAD4 and NCOR1. Binds to chromatin DNA via its DACHbox-N domain (By similarity). {ECO:0000250, ECO:0000269|PubMed:14525983}.
Ensembl transtripts involved in fusion geneENST idsENST00000514904, ENST00000381334, 
ENST00000506198, ENST00000542052, 
ENST00000305425, ENST00000313174, 
ENST00000354591, ENST00000359684, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score7 X 4 X 6=1685 X 5 X 3=75
# samples 95
** MAII scorelog2(9/168*10)=-0.900464326449086
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(5/75*10)=-0.584962500721156
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: TMEM165 [Title/Abstract] AND DACH1 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: TMEM165 [Title/Abstract] AND DACH1 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)TMEM165(56290810)-DACH1(72063280), # samples:2
Anticipated loss of major functional domain due to fusion event.TMEM165-DACH1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
TMEM165-DACH1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
TMEM165-DACH1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
TMEM165-DACH1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneTMEM165

GO:0032472

Golgi calcium ion transport

23569283

TgeneDACH1

GO:0000122

negative regulation of transcription by RNA polymerase II

20956529

TgeneDACH1

GO:0030336

negative regulation of cell migration

20956529

TgeneDACH1

GO:2000279

negative regulation of DNA biosynthetic process

16980615



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr4:56290810/chr13:72063280)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across TMEM165 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across DACH1 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000506198TMEM165chr456290810+ENST00000313174DACH1chr1372063280-37865461581096312
ENST00000506198TMEM165chr456290810+ENST00000305425DACH1chr1372063280-37865461581096312
ENST00000506198TMEM165chr456290810+ENST00000354591DACH1chr1372063280-37865461581096312
ENST00000506198TMEM165chr456290810+ENST00000359684DACH1chr1372063280-18065461581096312
ENST00000381334TMEM165chr456290810+ENST00000313174DACH1chr1372063280-437111311581681507
ENST00000381334TMEM165chr456290810+ENST00000305425DACH1chr1372063280-437111311581681507
ENST00000381334TMEM165chr456290810+ENST00000354591DACH1chr1372063280-437111311581681507
ENST00000381334TMEM165chr456290810+ENST00000359684DACH1chr1372063280-239111311581681507
ENST00000542052TMEM165chr456290810+ENST00000313174DACH1chr1372063280-446812285191778419
ENST00000542052TMEM165chr456290810+ENST00000305425DACH1chr1372063280-446812285191778419
ENST00000542052TMEM165chr456290810+ENST00000354591DACH1chr1372063280-446812285191778419
ENST00000542052TMEM165chr456290810+ENST00000359684DACH1chr1372063280-248812285191778419

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000506198ENST00000313174TMEM165chr456290810+DACH1chr1372063280-0.000340910.99965906
ENST00000506198ENST00000305425TMEM165chr456290810+DACH1chr1372063280-0.000340910.99965906
ENST00000506198ENST00000354591TMEM165chr456290810+DACH1chr1372063280-0.000340910.99965906
ENST00000506198ENST00000359684TMEM165chr456290810+DACH1chr1372063280-0.0017075210.9982925
ENST00000381334ENST00000313174TMEM165chr456290810+DACH1chr1372063280-0.0002648960.99973506
ENST00000381334ENST00000305425TMEM165chr456290810+DACH1chr1372063280-0.0002648960.99973506
ENST00000381334ENST00000354591TMEM165chr456290810+DACH1chr1372063280-0.0002648960.99973506
ENST00000381334ENST00000359684TMEM165chr456290810+DACH1chr1372063280-0.0017140850.99828595
ENST00000542052ENST00000313174TMEM165chr456290810+DACH1chr1372063280-0.0002728620.9997271
ENST00000542052ENST00000305425TMEM165chr456290810+DACH1chr1372063280-0.0002728620.9997271
ENST00000542052ENST00000354591TMEM165chr456290810+DACH1chr1372063280-0.0002728620.9997271
ENST00000542052ENST00000359684TMEM165chr456290810+DACH1chr1372063280-0.0016899540.9983101

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for TMEM165-DACH1

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
TMEM165chr456290810DACH1chr13720632801131324GGRMIAQKISVRTDETPLSTPTARDS
TMEM165chr456290810DACH1chr13720632801228236GGRMIAQKISVRTDETPLSTPTARDS
TMEM165chr456290810DACH1chr1372063280546129GGRMIAQKISVRTDETPLSTPTARDS

Top

Potential FusionNeoAntigen Information of TMEM165-DACH1 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
TMEM165-DACH1_56290810_72063280.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
TMEM165-DACH1chr456290810chr13720632801131HLA-C05:09RTDETPLST0.99930.95141120
TMEM165-DACH1chr456290810chr13720632801131HLA-C08:15RTDETPLST0.99310.96451120
TMEM165-DACH1chr456290810chr13720632801131HLA-C05:01RTDETPLST0.99930.95141120
TMEM165-DACH1chr456290810chr13720632801131HLA-C08:02RTDETPLST0.99310.96451120
TMEM165-DACH1chr456290810chr13720632801131HLA-B15:30SVRTDETPL0.83380.9049918

Top

Potential FusionNeoAntigen Information of TMEM165-DACH1 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
TMEM165-DACH1_56290810_72063280.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
TMEM165-DACH1chr456290810chr13720632801131DRB1-0301KISVRTDETPLSTPT722
TMEM165-DACH1chr456290810chr13720632801131DRB1-0301QKISVRTDETPLSTP621
TMEM165-DACH1chr456290810chr13720632801131DRB1-0307KISVRTDETPLSTPT722
TMEM165-DACH1chr456290810chr13720632801131DRB1-0310KISVRTDETPLSTPT722
TMEM165-DACH1chr456290810chr13720632801131DRB1-0313KISVRTDETPLSTPT722
TMEM165-DACH1chr456290810chr13720632801131DRB1-0313QKISVRTDETPLSTP621
TMEM165-DACH1chr456290810chr13720632801131DRB1-0315KISVRTDETPLSTPT722
TMEM165-DACH1chr456290810chr13720632801131DRB1-0315QKISVRTDETPLSTP621
TMEM165-DACH1chr456290810chr13720632801131DRB1-0318KISVRTDETPLSTPT722
TMEM165-DACH1chr456290810chr13720632801131DRB1-0318QKISVRTDETPLSTP621
TMEM165-DACH1chr456290810chr13720632801131DRB1-0320KISVRTDETPLSTPT722
TMEM165-DACH1chr456290810chr13720632801131DRB1-0320QKISVRTDETPLSTP621
TMEM165-DACH1chr456290810chr13720632801131DRB1-0322KISVRTDETPLSTPT722
TMEM165-DACH1chr456290810chr13720632801131DRB1-0322QKISVRTDETPLSTP621
TMEM165-DACH1chr456290810chr13720632801131DRB1-0326KISVRTDETPLSTPT722
TMEM165-DACH1chr456290810chr13720632801131DRB1-0326QKISVRTDETPLSTP621
TMEM165-DACH1chr456290810chr13720632801131DRB1-0326AQKISVRTDETPLST520
TMEM165-DACH1chr456290810chr13720632801131DRB1-0328KISVRTDETPLSTPT722
TMEM165-DACH1chr456290810chr13720632801131DRB1-0328QKISVRTDETPLSTP621
TMEM165-DACH1chr456290810chr13720632801131DRB1-0330KISVRTDETPLSTPT722
TMEM165-DACH1chr456290810chr13720632801131DRB1-0330QKISVRTDETPLSTP621
TMEM165-DACH1chr456290810chr13720632801131DRB1-0332KISVRTDETPLSTPT722
TMEM165-DACH1chr456290810chr13720632801131DRB1-0332QKISVRTDETPLSTP621
TMEM165-DACH1chr456290810chr13720632801131DRB1-0334KISVRTDETPLSTPT722
TMEM165-DACH1chr456290810chr13720632801131DRB1-0334QKISVRTDETPLSTP621
TMEM165-DACH1chr456290810chr13720632801131DRB1-0336KISVRTDETPLSTPT722
TMEM165-DACH1chr456290810chr13720632801131DRB1-0336QKISVRTDETPLSTP621
TMEM165-DACH1chr456290810chr13720632801131DRB1-0342KISVRTDETPLSTPT722
TMEM165-DACH1chr456290810chr13720632801131DRB1-0342QKISVRTDETPLSTP621
TMEM165-DACH1chr456290810chr13720632801131DRB1-0342AQKISVRTDETPLST520
TMEM165-DACH1chr456290810chr13720632801131DRB1-0344KISVRTDETPLSTPT722
TMEM165-DACH1chr456290810chr13720632801131DRB1-0344QKISVRTDETPLSTP621
TMEM165-DACH1chr456290810chr13720632801131DRB1-0346KISVRTDETPLSTPT722
TMEM165-DACH1chr456290810chr13720632801131DRB1-0346QKISVRTDETPLSTP621
TMEM165-DACH1chr456290810chr13720632801131DRB1-0348KISVRTDETPLSTPT722
TMEM165-DACH1chr456290810chr13720632801131DRB1-0348QKISVRTDETPLSTP621
TMEM165-DACH1chr456290810chr13720632801131DRB1-0350KISVRTDETPLSTPT722
TMEM165-DACH1chr456290810chr13720632801131DRB1-0350QKISVRTDETPLSTP621
TMEM165-DACH1chr456290810chr13720632801131DRB1-0352KISVRTDETPLSTPT722
TMEM165-DACH1chr456290810chr13720632801131DRB1-0352QKISVRTDETPLSTP621
TMEM165-DACH1chr456290810chr13720632801131DRB1-0354KISVRTDETPLSTPT722
TMEM165-DACH1chr456290810chr13720632801131DRB1-0354QKISVRTDETPLSTP621
TMEM165-DACH1chr456290810chr13720632801131DRB1-0401KISVRTDETPLSTPT722
TMEM165-DACH1chr456290810chr13720632801131DRB1-0401QKISVRTDETPLSTP621
TMEM165-DACH1chr456290810chr13720632801131DRB1-0413KISVRTDETPLSTPT722
TMEM165-DACH1chr456290810chr13720632801131DRB1-0413QKISVRTDETPLSTP621
TMEM165-DACH1chr456290810chr13720632801131DRB1-0413AQKISVRTDETPLST520
TMEM165-DACH1chr456290810chr13720632801131DRB1-0422KISVRTDETPLSTPT722
TMEM165-DACH1chr456290810chr13720632801131DRB1-0422QKISVRTDETPLSTP621
TMEM165-DACH1chr456290810chr13720632801131DRB1-0422AQKISVRTDETPLST520
TMEM165-DACH1chr456290810chr13720632801131DRB1-0422ISVRTDETPLSTPTA823
TMEM165-DACH1chr456290810chr13720632801131DRB1-0433KISVRTDETPLSTPT722
TMEM165-DACH1chr456290810chr13720632801131DRB1-0433QKISVRTDETPLSTP621
TMEM165-DACH1chr456290810chr13720632801131DRB1-0434KISVRTDETPLSTPT722
TMEM165-DACH1chr456290810chr13720632801131DRB1-0434QKISVRTDETPLSTP621
TMEM165-DACH1chr456290810chr13720632801131DRB1-0435KISVRTDETPLSTPT722
TMEM165-DACH1chr456290810chr13720632801131DRB1-0435QKISVRTDETPLSTP621
TMEM165-DACH1chr456290810chr13720632801131DRB1-0438KISVRTDETPLSTPT722
TMEM165-DACH1chr456290810chr13720632801131DRB1-0438QKISVRTDETPLSTP621
TMEM165-DACH1chr456290810chr13720632801131DRB1-0444KISVRTDETPLSTPT722
TMEM165-DACH1chr456290810chr13720632801131DRB1-0444QKISVRTDETPLSTP621
TMEM165-DACH1chr456290810chr13720632801131DRB1-0462KISVRTDETPLSTPT722
TMEM165-DACH1chr456290810chr13720632801131DRB1-0462QKISVRTDETPLSTP621
TMEM165-DACH1chr456290810chr13720632801131DRB1-0463KISVRTDETPLSTPT722
TMEM165-DACH1chr456290810chr13720632801131DRB1-0463QKISVRTDETPLSTP621
TMEM165-DACH1chr456290810chr13720632801131DRB1-0464KISVRTDETPLSTPT722
TMEM165-DACH1chr456290810chr13720632801131DRB1-0464QKISVRTDETPLSTP621
TMEM165-DACH1chr456290810chr13720632801131DRB1-0466KISVRTDETPLSTPT722
TMEM165-DACH1chr456290810chr13720632801131DRB1-0466QKISVRTDETPLSTP621
TMEM165-DACH1chr456290810chr13720632801131DRB1-0467KISVRTDETPLSTPT722
TMEM165-DACH1chr456290810chr13720632801131DRB1-0467QKISVRTDETPLSTP621
TMEM165-DACH1chr456290810chr13720632801131DRB1-0470KISVRTDETPLSTPT722
TMEM165-DACH1chr456290810chr13720632801131DRB1-0472KISVRTDETPLSTPT722
TMEM165-DACH1chr456290810chr13720632801131DRB1-0472QKISVRTDETPLSTP621
TMEM165-DACH1chr456290810chr13720632801131DRB1-0476KISVRTDETPLSTPT722
TMEM165-DACH1chr456290810chr13720632801131DRB1-0476QKISVRTDETPLSTP621
TMEM165-DACH1chr456290810chr13720632801131DRB1-1107KISVRTDETPLSTPT722
TMEM165-DACH1chr456290810chr13720632801131DRB1-1476KISVRTDETPLSTPT722
TMEM165-DACH1chr456290810chr13720632801131DRB1-1476QKISVRTDETPLSTP621
TMEM165-DACH1chr456290810chr13720632801131DRB1-1479KISVRTDETPLSTPT722
TMEM165-DACH1chr456290810chr13720632801131DRB1-1479QKISVRTDETPLSTP621
TMEM165-DACH1chr456290810chr13720632801131DRB3-0201KISVRTDETPLSTPT722
TMEM165-DACH1chr456290810chr13720632801131DRB3-0204KISVRTDETPLSTPT722
TMEM165-DACH1chr456290810chr13720632801131DRB3-0204QKISVRTDETPLSTP621
TMEM165-DACH1chr456290810chr13720632801131DRB3-0224KISVRTDETPLSTPT722

Top

Fusion breakpoint peptide structures of TMEM165-DACH1

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
7344QKISVRTDETPLSTTMEM165DACH1chr456290810chr13720632801131

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of TMEM165-DACH1

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN7344QKISVRTDETPLST-7.15543-7.26883
HLA-B14:023BVN7344QKISVRTDETPLST-4.77435-5.80965
HLA-B52:013W397344QKISVRTDETPLST-6.80875-6.92215
HLA-B52:013W397344QKISVRTDETPLST-4.20386-5.23916
HLA-A11:014UQ27344QKISVRTDETPLST-7.5194-8.5547
HLA-A11:014UQ27344QKISVRTDETPLST-6.9601-7.0735
HLA-A24:025HGA7344QKISVRTDETPLST-7.52403-7.63743
HLA-A24:025HGA7344QKISVRTDETPLST-5.82433-6.85963
HLA-B27:056PYJ7344QKISVRTDETPLST-3.28285-4.31815
HLA-B44:053DX87344QKISVRTDETPLST-5.91172-6.94702
HLA-B44:053DX87344QKISVRTDETPLST-4.24346-4.35686

Top

Vaccine Design for the FusionNeoAntigens of TMEM165-DACH1

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
TMEM165-DACH1chr456290810chr13720632801120RTDETPLSTGAACTGATGAGACCCCGCTTTCTACAC
TMEM165-DACH1chr456290810chr1372063280918SVRTDETPLCTGTCAGAACTGATGAGACCCCGCTTT

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
TMEM165-DACH1chr456290810chr1372063280520AQKISVRTDETPLSTCACAGAAAATCTCTGTCAGAACTGATGAGACCCCGCTTTCTACAC
TMEM165-DACH1chr456290810chr1372063280621QKISVRTDETPLSTPAGAAAATCTCTGTCAGAACTGATGAGACCCCGCTTTCTACACCAA
TMEM165-DACH1chr456290810chr1372063280722KISVRTDETPLSTPTAAATCTCTGTCAGAACTGATGAGACCCCGCTTTCTACACCAACCG
TMEM165-DACH1chr456290810chr1372063280823ISVRTDETPLSTPTATCTCTGTCAGAACTGATGAGACCCCGCTTTCTACACCAACCGCAA

Top

Information of the samples that have these potential fusion neoantigens of TMEM165-DACH1

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
OVTMEM165-DACH1chr456290810ENST00000381334chr1372063280ENST00000305425TCGA-29-1778-01A

Top

Potential target of CAR-T therapy development for TMEM165-DACH1

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note
HgeneTMEM165chr4:56290810chr13:72063280ENST00000381334+56127_147299325.0TransmembraneHelical
HgeneTMEM165chr4:56290810chr13:72063280ENST00000381334+56152_172299325.0TransmembraneHelical
HgeneTMEM165chr4:56290810chr13:72063280ENST00000381334+56229_249299325.0TransmembraneHelical
HgeneTMEM165chr4:56290810chr13:72063280ENST00000381334+56268_288299325.0TransmembraneHelical
HgeneTMEM165chr4:56290810chr13:72063280ENST00000381334+5690_110299325.0TransmembraneHelical

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to TMEM165-DACH1

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to TMEM165-DACH1

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource